Study of Combined GARP:TGF-β1/PD-1 Blockade as a Shock-and-kill Strategy in HIV-1 Cure
NCT07692932
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
HIV -1 Infection
Interventions
OTHER:
blood drawn
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain